ABRAXIS BIOSCIENCE, LLC

2020 N Ruby St, Melrose Park, Illinois, United States

Clinical Trials

3 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

33.3%

Trial Status Distribution

Active, not recruiting

100.0%

Clinical Trials

Trials sponsored by this organization (3)

An Open-Label, Multicenter, Phase III Trial of ABI-007 vs. Dacarbazine in Previously Untreated Patients with Metastatic Malignant Melanoma - ND

Active, not recruiting

Jul 2009514 participants

Estudio en fase III, abierto y multicéntrico de ABI-007 frente a dacarbazina en pacientes con melanoma maligno metastásico no tratados previamente.An Open-Label, Multicenter, Phase III Trial of ABI-007 vs Dacarbazine in Previously Untreated Patients with Metastatic Malignant Melanoma.

Active, not recruiting

Jun 2009514 participants

An Open-Label, Multicenter, Phase III Trial of ABI-007 vs Dacarbazine in Previously Untreated Patients with Metastatic Malignant Melanoma

Phase 1

Active, not recruiting

Jun 2009529 participants

Approvals

Approvals by Agency

FDA

Food and Drug Administration

Approvals

SFDA

Saudi Food and Drug Authority

Approvals

Recent Approvals

News

No news articles found

Back to Organizations